Role of vascular endothelial growth factor in keloids: A clinicopathologic study

International Journal of Dermatology

Volumn 48, Issue 10, 2009, Pages 1071-1077

  Salem, Ahmed ^a   Assaf, Magda ^a   Helmy, Afaf ^a   Nofal, Ahmad ^a   Ibrahim, Samia ^a   Eldeeb, Fatma ^a   Youssef, Christeen ^a  

^a ZAGAZIG UNIVERSITY   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; TRIAMCINOLONE ACETONIDE; VASCULOTROPIN;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CRYOTHERAPY; DRUG RESPONSE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERPIGMENTATION; HYPERTRICHOSIS; HYPOPIGMENTATION; KELOID; MALE; PAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SYNTHESIS REGULATION; SCHOOL CHILD; SKIN ATROPHY; SKIN BIOPSY; SKIN INFECTION; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADOLESCENT; ADULT; CHILD; FEMALE; HUMANS; KELOID; MALE; MIDDLE AGED; VASCULAR ENDOTHELIAL GROWTH FACTOR A; YOUNG ADULT;

EID: 70349498670     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2009.04143.x     Document Type: Article

References (31)

1. Butler PD, Ly DP, Longaker MT, et al. Use of organotypic coculture to study keloid biology. Am J Surg 2008, 195:144-148.
2. Mutalik S. Treatment of keloids and hypertrophic scars. Indian J Dermatol Venereol Leprol 2005, 71:3-8.
3. Al-Attar A, Mess S, Thomassen JM, et al. Keloid pathogenesis and treatment. Plast Reconstr Surg 2006, 117:286-300.
4. Gao Z, Wang Z, Shi Y, et al. Modulation of collagen synthesis in keloid fibroblasts by silencing Smad2 with siRNA. Plast Reconstr Surg 2006, 118:1328-1337.
5. Wu WS, Wang FS, Yang KD, et al. Dexamethasone induction of keloid regression through effective suppression of VEGF expression and keloid fibroblast proliferation. J Invest Dermatol 2006, 126:1264-1271.
6. Bayat A, Arscott G, Ollier WE, et al. "Aggressive keloid" : a severe variant of familial keloid scarring. J R Soc Med 2003, 96:554-555.
7. Robles DT, Moore E, Draznin M, et al. Keloids: pathophysiology and management. Dermatol Online J 2007, 13:9.
8. Saed GM, Ladin D, Olson J, et al. Analysis of p53 gene mutations in keloids using polymerase chain reaction-based single-strand conformational polymorphism and DNA sequencing. Arch Dermatol 1998, 134:963-967.
9. Tanaka A, Hatoko M, Tada H, et al. Expression of p53 family in scars. J Dermatol Sci 2004, 34:17-24.
10. Shaffer JJ, Taylor SC, Cook-Bolden F. Keloidal scars: a review with a critical look at therapeutic options. J Am Acad Dermatol 2002, 46:S63-S97.
11. Butler PD, Longaker MT, Yang GP. Current progress in keloid research and treatment. J Am Coll Surg 2008, 206:731-741.
12. Akaishi S, Ogawa R, Hyakusoku H. Keloid and hypertrophic scar: neurogenic inflammation hypotheses. Med Hypotheses 2008, 71:32-38.
13. Xue H, McCauley RL, Zhang W. Elevated interleukin-6 expression in keloid fibroblasts. J Surg Res 2000, 89:74-77.
14. Chau CH, Clavijo CA, Deng HT, et al. Etk/Bmx mediates expression of stress-induced adaptive genes VEGF, PAI-1, and iNOS via multiple signaling cascades in different cell systems. Am J Physiol Cell Physiol 2005, 289:C444-C454.
15. Giugliano G, Pasquali D, Notaro A, et al. Verapamil inhibits interleukin-6 and vascular endothelial growth factor production in primary cultures of keloid fibroblasts. Br J Plast Surg 2003, 56:804-809.
16. Mofikoya BO, Adeyemo WL, Abdus-salam AA. Keloid and hypertrophic scars: a review of recent developments in pathogenesis and management. Nig Q J Hosp Med 2007, 17:134-139.
17. Rekha A. Keloids-a frustrating hurdle in wound healing. Int Wound J 2004, 1:145-148.
18. Nanda S, Reddy BS. Intralesional 5-fluorouracil as a treatment modality of keloids. Dermatol Surg 2004, 30:54-56.
19. Le AD, Zhang Q, Wu Y. Elevated vascular endothelial growth factor in keloids: relevance to tissue fibrosis. Cells Tissues Organs 2004, 176:87-94.
20. Ong CT, Khoo YT, Tan EK, et al. Epithelial-mesenchymal interactions in keloid pathogenesis modulate vascular endothelial growth factor expression and secretion. J Pathol 2007, 211:95-108.
21. Fujiwara M, Muragaki Y, Ooshima A. Upregulation of transforming growth factor-beta1 and vascular endothelial growth factor in cultured keloid fibroblasts: relevance to angiogenic activity. Arch Dermatol Res 2005, 297:161-169.
22. Jiang DY, Fu XB, Chen W, et al. Relationship of overexpression of angiogenesis factors and their receptors with invasive growth of keloid. Zhonghua Zheng Xing Wai Ke Za Zhi 2004, 20:128-131.
23. Wu Y, Zhang Q, Ann DK, et al. Increased vascular endothelial growth factor may account for elevated level of plasminogen activator inhibitor-1 via activating ERK1/2 in keloid fibroblasts. Am J Physiol Cell Physiol 2004, 286:C905-C912.
24. Cukierman E, Pankov R, Stevens DR, et al. Taking cell-matrix adhesions to the third dimension. Science 2001, 294:1708-1712.
25. Atamas SP. Complex cytokine regulation of tissue fibrosis. Life Sci 2002, 72:631-643.
26. Yang GP, Lim IJ, Phan TT, et al. From scarless fetal wounds to keloids: molecular studies in wound healing. Wound Repair Regen 2003, 11:411-418.
27. Gira AK, Brown LF, Washington CV, et al. Keloids demonstrate high-level epidermal expression of vascular endothelial growth factor. J Am Acad Dermatol 2004, 50:850-853.
28. Reish RG, Eriksson E. Scar treatments: preclinical and clinical studies. J Am Coll Surg 2008, 206:719-730.
29. Rusciani L, Paradisi A, Alfano C, et al. Cryotherapy in the treatment of keloids. J Drugs Dermatol 2006, 5:591-595.
30. Dalkowski A, Fimmel S, Beutler C, et al. Cryotherapy modifies synthetic activity and differentiation of keloidal fibroblasts in vitro. Exp Dermatol 2003, 12:673-681.
31. Zhang GY, Yi CG, Li X, et al. Inhibition of vascular endothelial growth factor expression in keloid fibroblasts by vector-mediated vascular endothelial growth factor shRNA: a therapeutic potential strategy for keloid. Arch Dermatol Res 2008, 300:177-184.